Fusion protein

• 收藏
• 分享

专利权人:

Viravaxx AG

发明人:

Valenta, Rudolf,Cornelius, Carolin

申请号：

AU2016316811

公开号：

AU2016316811A1

申请日:

2016.09.05

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present invention relates to a fusion protein for use in the treatment and/or prevention of a hepatitis B virus infection comprising at least one hepatitis B PreS polypeptide or fragment thereof fused to at least one peptide consisting of an amino acid sequence having at least 80% identity to a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 and SEQ ID No. 4.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/